Lv3
400 积分 2023-11-14 加入
Development of a Novel CLDN18.2-directed Monoclonal Antibody and Antibody–Drug Conjugate for Treatment of CLDN18.2-Positive Cancers
26天前
已完结
KRAS mutation-driven O-GlcNAcylation of CLDN18.2 enhances the progression of pancreatic cancer and reduces the efficacy of CLDN18.2-targeted therapy
27天前
已完结
Claudin-1 targeting suppresses tumor growth, invasion, and metastasis in patient-derived cholangiocarcinoma models
28天前
已完结
Clinical Translation of a Dual-Integrin αvβ3- and CD13-Targeting PET Tracer
1个月前
已完结
Efficacy of CLDN18.2-Targeted Radiotheranostics in Patient-Derived Models of Gastric Cancer
1个月前
已完结
Noninvasive Imaging of Claudin 18.2 Expression in Gastric Adenocarcinoma: Synthesis, Preclinical Evaluation, and Preliminary Clinical Study of a Novel [89Zr]Zr-DFO-NY005 Immuno-Positron Emission Tomography Tracer
1个月前
已完结
Peptide-Based ROR1-Targeting PET Ligands for Melanoma Tumor Imaging: Design and Preclinical Evaluation
2个月前
已完结
Nitroimidazole-Containing [ 68 Ga]Ga-IPM-N001 as a New CAIX-Targeting Radionuclide Tracer
2个月前
已完结
A liver-targeting fluorescent nano-drug for theranostics in non-alcoholic fatty liver disease
2个月前
已完结
An Anti-EGFR Antibody–Drug Radioconjugate Labeled with Actinium-225 Elicits Durable Antitumor Responses in KRAS- and BRAF-Mutant Colorectal Cancer
2个月前
已完结
皖公网安备34019202002308
